메뉴 건너뛰기




Volumn 16, Issue 4, 2014, Pages 198-203

Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C PEPTIDE; CREATININE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

EID: 84896374662     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0205     Document Type: Article
Times cited : (94)

References (29)
  • 1
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus
    • The Diabetes Control and Complications Trial (DCCT) Research Group
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. The Diabetes Control and Complications Trial (DCCT) Research Group. N Engl J Med 1993;329:977-986.
    • (1993) N Engl J Med , vol.329 , pp. 977-986
  • 2
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 4
    • 0142087597 scopus 로고    scopus 로고
    • Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic ne-phropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study DCCT/EDIC Research Group
    • Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic ne-phropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. DCCT/EDIC Research Group. JAMA 2003;290:2159-2167.
    • (2003) JAMA , vol.290 , pp. 2159-2167
  • 5
    • 18144415490 scopus 로고    scopus 로고
    • Should minimal blood glucose variability become the gold standard of glycemic control?
    • DOI 10.1016/j.jdiacomp.2004.10.001
    • Hirsch IB, Brownlee M: Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005;19:178-181. (Pubitemid 40615551)
    • (2005) Journal of Diabetes and its Complications , vol.19 , Issue.3 , pp. 178-181
    • Hirsch, I.B.1    Brownlee, M.2
  • 6
    • 0036021736 scopus 로고    scopus 로고
    • Postprandial hyperglycaemia: Noxious effects on the vessel wall
    • Hanefeld M: Postprandial hyperglycaemia: noxious effects on the vessel wall. Int J Clin Pract Suppl 2002;129:45-50.
    • (2002) Int J Clin Pract Suppl , vol.129 , pp. 45-50
    • Hanefeld, M.1
  • 7
    • 41149091612 scopus 로고    scopus 로고
    • Glycemic variability: Should we and can we prevent it?
    • Monnier L, Colette C: Glycemic variability: should we and can we prevent it? Diabetes Care 2008;31(Suppl 2):S150-S154.
    • (2008) Diabetes Care , vol.31 , Issue.SUPPL. 2
    • Monnier, L.1    Colette, C.2
  • 9
    • 33645732339 scopus 로고    scopus 로고
    • Glycemic variability: A hemoglobin A1c-independent risk factor for diabetic complications
    • Brownlee M, Hirsch IB: Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 2006;295:1707-1708.
    • (2006) JAMA , vol.295 , pp. 1707-1708
    • Brownlee, M.1    Hirsch, I.B.2
  • 10
    • 0035856980 scopus 로고    scopus 로고
    • Biochemistry and molecular cell biology of diabetic complications
    • Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-821.
    • (2001) Nature , vol.414 , pp. 813-821
    • Brownlee, M.1
  • 11
    • 20044376702 scopus 로고    scopus 로고
    • The pathobiology of diabetic complications: A unifying mechanism
    • DOI 10.2337/diabetes.54.6.1615
    • Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-1625. (Pubitemid 40770750)
    • (2005) Diabetes , vol.54 , Issue.6 , pp. 1615-1625
    • Brownlee, M.1
  • 12
    • 53349101264 scopus 로고    scopus 로고
    • Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia
    • El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M: Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008;205: 2409-2417.
    • (2008) J Exp Med , vol.205 , pp. 2409-2417
    • El-Osta, A.1    Brasacchio, D.2    Yao, D.3    Pocai, A.4    Jones, P.L.5    Roeder, R.G.6    Cooper, M.E.7    Brownlee, M.8
  • 14
    • 33645745733 scopus 로고    scopus 로고
    • Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglyce-mia in patients with type 2 diabetes
    • Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglyce-mia in patients with type 2 diabetes. JAMA 2006;295:1681-1687.
    • (2006) JAMA , vol.295 , pp. 1681-1687
    • Monnier, L.1    Mas, E.2    Ginet, C.3    Michel, F.4    Villon, L.5    Cristol, J.P.6    Colette, C.7
  • 15
    • 79957989692 scopus 로고    scopus 로고
    • No relevant relationship between glucose variability and oxidative stress in well-regulated type 2 diabetes patients
    • Siegelaar SE, Barwari T, Kulik W, Hoekstra JB, DeVries JH: No relevant relationship between glucose variability and oxidative stress in well-regulated type 2 diabetes patients. J Diabetes Sci Technol 2011;5:86-92.
    • (2011) J Diabetes Sci Technol , vol.5 , pp. 86-92
    • Siegelaar, S.E.1    Barwari, T.2    Kulik, W.3    Hoekstra, J.B.4    Devries, J.H.5
  • 16
    • 36649006065 scopus 로고    scopus 로고
    • Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes
    • DOI 10.1007/s00125-007-0842-6
    • Wentholt IM, Kulik W, Michels RP, Hoekstra JB, DeVries JH: Glucose fluctuations and activation of oxidative stress in type 1 diabetes patients. Diabetologia 2008;51:183-190. (Pubitemid 50002199)
    • (2008) Diabetologia , vol.51 , Issue.1 , pp. 183-190
    • Wentholt, I.M.E.1    Kulik, W.2    Michels, R.P.J.3    Hoekstra, J.B.L.4    DeVries, J.H.5
  • 18
    • 57049128707 scopus 로고    scopus 로고
    • Can glycaemic variability as calculated from blood glucose self-monitoring predict the development of complications in type 1 diabetes over a decade?
    • Bragd J, Adamson U, Bäcklund LB, Lins PE, Moberg E, Oskarsson P: Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab 2008;34:612-616.
    • (2008) Diabetes Metab , vol.34 , pp. 612-616
    • Bragd, J.1    Adamson, U.2    Bäcklund, L.B.3    Lins, P.E.4    Moberg, E.5    Oskarsson, P.6
  • 19
    • 70349653641 scopus 로고    scopus 로고
    • Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes
    • Kilpatrick ES, Rigby AS, Atkin SL: Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 2009;32:1901-1903.
    • (2009) Diabetes Care , vol.32 , pp. 1901-1903
    • Kilpatrick, E.S.1    Rigby, A.S.2    Atkin, S.L.3
  • 20
    • 42449121829 scopus 로고    scopus 로고
    • DCCT/EDIC Research Group: Effect of glycemic exposure on the risk of microvascular complications in the Diabetes Control and Complications Trial-revisited
    • Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN; DCCT/EDIC Research Group: Effect of glycemic exposure on the risk of microvascular complications in the Diabetes Control and Complications Trial-revisited. Diabetes 2008; 57:995-1001.
    • (2008) Diabetes , vol.57 , pp. 995-1001
    • Lachin, J.M.1    Genuth, S.2    Nathan, D.M.3    Zinman, B.4    Rutledge, B.N.5
  • 21
    • 79952998106 scopus 로고    scopus 로고
    • The minimum frequency of glucose measurements from which glycemic variation can be consistently assessed
    • Baghurst PA, Rodbard D, Cameron FJ: The minimum frequency of glucose measurements from which glycemic variation can be consistently assessed. J Diabetes Sci Technol 2010;4:1382-1385.
    • (2010) J Diabetes Sci Technol , vol.4 , pp. 1382-1385
    • Baghurst, P.A.1    Rodbard, D.2    Cameron, F.J.3
  • 22
    • 0032938574 scopus 로고    scopus 로고
    • Detection of microalbuminuria: Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration
    • DOI 10.2337/diacare.22.2.307
    • Bakker AJ: Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 1999;22:307-313. (Pubitemid 29056927)
    • (1999) Diabetes Care , vol.22 , Issue.2 , pp. 307-313
    • Bakker, A.J.1
  • 23
    • 49649087783 scopus 로고    scopus 로고
    • American Association of Clinical Endo-crinologists: Comprehensive foot examination and risk assessment: A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical En-docrinologists
    • Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hell-man R, Kirkman MS, Lavery LA, Lemaster JW, Mills JL Sr, Mueller MJ, Sheehan P, Wukich DK; AmericanDiabetes Association; American Association of Clinical Endo-crinologists: Comprehensive foot examination and risk assessment: a report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical En-docrinologists. Diabetes Care 2008;31:1679-1685.
    • (2008) Diabetes Care , vol.31 , pp. 1679-1685
    • Boulton, A.J.1    Armstrong, D.G.2    Albert, S.F.3    Frykberg, R.G.4    Hell-Man, R.5    Kirkman, M.S.6    Lavery, L.A.7    Lemaster, J.W.8    Mills, J.L.S.R.9    Mueller, M.J.10    Sheehan, P.11    Wukich, D.K.12
  • 24
    • 70349249912 scopus 로고    scopus 로고
    • Interpretation of continuous glucose monitoring data: Glycemic variability and quality of glycemic control
    • Rodbard D: Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther 2009;11(Suppl 1):S-55-S-67.
    • (2009) Diabetes Technol Ther , vol.11 , Issue.SUPPL. 1
    • Rodbard, D.1
  • 25
    • 77955677620 scopus 로고    scopus 로고
    • Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: A cross-sectional, observational study
    • Greven WL, Beulens JW, Biesma DH, Faiz S, de Valk HW: Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational study. Diabetes Technol Ther 2010;12:695-699.
    • (2010) Diabetes Technol Ther , vol.12 , pp. 695-699
    • Greven, W.L.1    Beulens, J.W.2    Biesma, D.H.3    Faiz, S.4    De Valk, H.W.5
  • 27
    • 77953637843 scopus 로고    scopus 로고
    • Gly-caemic variability and complications in patients with diabetes mellitus: Evidence from a systematic review of the literature
    • Nalysnyk L, Hernandez-Medina M, Krishnarajah G: Gly-caemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab 2010;12:288-298.
    • (2010) Diabetes Obes Metab , vol.12 , pp. 288-298
    • Nalysnyk, L.1    Hernandez-Medina, M.2    Krishnarajah, G.3
  • 28
    • 33746460818 scopus 로고    scopus 로고
    • The effect of glucose variability on the risk of microvascular complications in type 1 diabetes
    • DOI 10.2337/dc06-0293
    • Kilpatrick ES, Rigby AS, Atkin SL: The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006;29:1486-1490. (Pubitemid 44127568)
    • (2006) Diabetes Care , vol.29 , Issue.7 , pp. 1486-1490
    • Kilpatrick, E.S.1    Rigby, A.S.2    Atkin, S.L.3
  • 29
    • 69949164144 scopus 로고    scopus 로고
    • Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: Data from the DCCT
    • Siegelaar SE, Kilpatrick ES, Rigby AS, Atkin SL, Hoekstra JB, Devries JH: Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT. Diabetologia 2009;52: 2229-2232.
    • (2009) Diabetologia , vol.52 , pp. 2229-2232
    • Siegelaar, S.E.1    Kilpatrick, E.S.2    Rigby, A.S.3    Atkin, S.L.4    Hoekstra, J.B.5    Devries, J.H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.